Efficacy of pulmonary surfactant with budesonide in infants born at or less than 28 weeks’ gestation: a systematic review and meta-analysis
Abstract Pulmonary surfactant (PS) is the standard treatment for respiratory distress syndrome in preterm infants. Budesonide, a corticosteroid with anti-inflammatory properties, has been studied for use with PS to potentially improve respiratory outcomes and reduce bronchopulmonary dysplasia (BPD)...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2025-12-01
|
| シリーズ: | Scientific Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1038/s41598-025-33028-0 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|